{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:47:23Z","timestamp":1793317643965,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":287,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jdsjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jdermsci.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T12:06:48Z","timestamp":1542974808000},"page":"2-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Regulatory and effector B cells: Friends or foes?"],"prefix":"10.1016","volume":"93","author":[{"given":"Takashi","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdermsci.2018.11.008_bib0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.180.4.1295","article-title":"The role of B cells in lpr\/lpr-induced autoimmunity","volume":"180","author":"Shlomchik","year":"1994","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.jdermsci.2018.11.008_bib0010","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.11.008_bib0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jdermsci.2018.11.008_bib0020","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.jdermsci.2018.11.008_bib0025","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.4049\/jimmunol.0902391","article-title":"Protective and pathogenic roles for B cells during systemic autoimmunity in NZB\/W F1 mice","volume":"184","author":"Haas","year":"2010","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jdermsci.2018.11.008_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nri3857","article-title":"Antibody-independent functions of B cells: a focus on cytokines","volume":"15","author":"Shen","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0035","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.jdermsci.2018.11.008_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.jdermsci.2018.11.008_bib0045","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1084\/jem.186.10.1749","article-title":"Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice","volume":"186","author":"Mizoguchi","year":"1997","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0050","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","article-title":"Selective targeting of B cells with agonistic Anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-Like B cells and for the suppression of lupus in MRL\/lpr mice","volume":"182","author":"Blair","year":"2009","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.11.008_bib0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/intimm\/dxn031","article-title":"Regulatory role of B-1 B cells in chronic colitis","volume":"20","author":"Shimomura","year":"2008","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.11.008_bib0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1084\/jem.20062013","article-title":"Type I interferons protect neonates from acute inflammation through interleukin 10-producing B cells","volume":"204","author":"Zhang","year":"2007","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.11.008_bib0070","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaci.2015.12.1319","article-title":"A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation","volume":"138","author":"Matsushita","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0075","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.celrep.2015.09.070","article-title":"Transcriptomics identify CD9 as a marker of murine IL-10-Competent regulatory B cells","volume":"13","author":"Sun","year":"2015","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0080","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"issue":"7492","key":"10.1016\/j.jdermsci.2018.11.008_bib0085","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.11.008_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2018.06.007","article-title":"LAG-3 inhibitory receptor expression identifies immunosuppressive natural regulatory plasma cells","volume":"49","author":"Lino","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.11.008_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2010.08.010","article-title":"Regulatory B cells in skin and connective tissue diseases","volume":"60","author":"Fujimoto","year":"2010","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.11.008_bib0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.11.008_bib0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.jdermsci.2018.11.008_bib0110","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1182\/blood-2014-09-599159","article-title":"CD24(hi)CD27(+) and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","volume":"125","author":"de Masson","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jdermsci.2018.11.008_bib0115","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jaci.2015.09.014","article-title":"In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles","volume":"137","author":"Simon","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.11.008_bib0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology Oxford (Oxford)"},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.jdermsci.2018.11.008_bib0130","doi-asserted-by":"crossref","first-page":"e0710","DOI":"10.1097\/MD.0000000000010710","article-title":"IL-35-producing B cells in gastric cancer patients","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0135","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/mi.2012.42","article-title":"Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-beta, and co-localize with CD4+Foxp3+ T cells","volume":"5","author":"Natarajan","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"10","key":"10.1016\/j.jdermsci.2018.11.008_bib0140","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/all.12218","article-title":"Tolerogenic CX3CR1+ B cells suppress food allergy-induced intestinal inflammation in mice","volume":"68","author":"Liu","year":"2013","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0145","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/eji.201344062","article-title":"TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance","volume":"44","author":"Lee","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jdermsci.2018.11.008_bib0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2015.02.004","article-title":"B-Cells induce regulatory T cells through TGF-beta\/IDO production in A CTLA-4 dependent manner","volume":"59","author":"Nouel","year":"2015","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.11.008_bib0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/82717","article-title":"Reciprocal regulation of polarized cytokine production by effector B and T cells","volume":"1","author":"Harris","year":"2000","journal-title":"Nat. Immunol."},{"issue":"310","key":"10.1016\/j.jdermsci.2018.11.008_bib0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.11.008_bib0165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.jdermsci.2018.11.008_bib0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aas9944","article-title":"BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance","volume":"4","author":"Matsushita","year":"2018","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.11.008_bib0175","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.11.008_bib0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/cr.2013.155","article-title":"Identification of IFN-gamma-producing innate B cells","volume":"24","author":"Bao","year":"2014","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.11.008_bib0185","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/eji.201445036","article-title":"B cells expressing IFN-gamma suppress Treg-cell differentiation and promote autoimmune experimental arthritis","volume":"45","author":"Olalekan","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.jdermsci.2018.11.008_bib0190","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4049\/jimmunol.1602107","article-title":"TIM-4 identifies IFN-gamma-Expressing proinflammatory B effector 1 cells that promote tumor and allograft rejection","volume":"199","author":"Ding","year":"2017","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.jdermsci.2018.11.008_bib0195","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1136\/ard.2011.153312","article-title":"Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis","volume":"70","author":"Yeo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"6068","key":"10.1016\/j.jdermsci.2018.11.008_bib0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1126\/science.1215173","article-title":"Innate response activator B cells protect against microbial sepsis","volume":"335","author":"Rauch","year":"2012","journal-title":"Science"},{"issue":"suppl 10","key":"10.1016\/j.jdermsci.2018.11.008_bib0205","article-title":"GM-CSF-Producing B cells: a novel B cell subset involved in the pathogenesis of systemic sclerosis [abstract]","volume":"69","author":"Higashioka","year":"2017","journal-title":"."},{"issue":"9","key":"10.1016\/j.jdermsci.2018.11.008_bib0210","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.jdermsci.2018.11.008_bib0215","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1084\/jem.20170580","article-title":"B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity","volume":"214","author":"Arkatkar","year":"2017","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jdermsci.2018.11.008_bib0220","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"issue":"9767","key":"10.1016\/j.jdermsci.2018.11.008_bib0225","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.jdermsci.2018.11.008_bib0230","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1182\/blood-2012-11-465658","article-title":"Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease","volume":"121","author":"Le Huu","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jdermsci.2018.11.008_bib0235","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/jid.2012.226","article-title":"IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease","volume":"132","author":"Le Huu","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"10038","key":"10.1016\/j.jdermsci.2018.11.008_bib0240","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jdermsci.2018.11.008_bib0245","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/art.40390","article-title":"Association of defective regulation of autoreactive Interleukin-6-Producing transitional B lymphocytes with disease in patients with systemic sclerosis","volume":"70","author":"Taher","year":"2018","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"2","key":"10.1016\/j.jdermsci.2018.11.008_bib0250","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/art.40358","article-title":"Belimumab for the treatment of early diffuse systemic sclerosis: results of a randomized, double-blind, placebo-controlled, pilot trial","volume":"70","author":"Gordon","year":"2018","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118304134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118304134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T03:06:27Z","timestamp":1572231987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181118304134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0923181118304134"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.11.008","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory and effector B cells: Friends or foes?","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author. Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}